文献速递肿瘤 PET/CT神经核医学

传统与模糊影像组学在临床癌症影像队列中的机器学习预测性能评估

Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-02-04

该研究基于已发表的11C-蛋氨酸PET胶质瘤、18F-FDG PET/CT肺癌和68GA-PSMA-11 PET/MRI前列腺癌回顾性队列,比较模糊影像组学与传统二值影像组学的机器学习预测性能。结果显示参考模糊勾画在全部队列中优于二值勾画,相对交叉验证AUC提高4.7至10.4,模糊影像组学使特征冗余减少约20%。作者认为模糊影像组学在小病灶中可能提升预测性能。

要点

  • 参考模糊勾画在全部三个队列中优于对应二值勾画,相对交叉验证AUC提高4.7至10.4。
  • 胶质瘤队列中参考模糊勾画AUC为0.74,参考二值勾画AUC为0.70。
  • 模糊影像组学使特征冗余减少约20%。

核心结论

  • 作者认为模糊影像组学相比传统二值影像组学在PET中可能提升预测性能,尤其在小病灶尺寸时。
  • 作者推测该效应源于模糊影像组学能够建模小病灶边界的部分容积效应和勾画不确定性。
  • 作者认为模糊影像组学特征冗余较低,有助于未来研究中识别影像生物标志物。

研究设计与样本

  • 研究纳入已发表的11C-蛋氨酸PET胶质瘤、18F-FDG PET/CT肺癌和68GA-PSMA-11 PET/MRI前列腺癌回顾性队列以预测各自临床终点。
  • 采用四种勾画方法:手动定义的参考二值勾画(Ref-B)、其平滑模糊化版本(Ref-F)、扩展二值勾画(Ext-B)及其模糊化版本(Ext-F)。
  • 从每个队列提取符合影像生物标志物标准化倡议(IBSI)的影像组学特征。
  • 对四种勾画方法采用蒙特卡洛交叉验证方案进行机器学习以估计预测性能。

主要发现

  • 参考模糊勾画(Ref-F)在全部队列中优于其对应二值勾画(Ref-B),体积范围为938至354987 mm³,相对交叉验证受试者工作特征曲线下面积(AUC)为+4.7至10.4。
  • 与Ref-B相比,胶质瘤队列中Ref-F勾画的AUC性能差异最高(Ref-F:0.74 vs Ref-B:0.70)。
  • 前列腺癌队列中Ref-F和Ext-F相较Ref-B的AUC为(Ref-F:0.84、Ext-F:0.86 vs Ref-B:0.80)。
  • 模糊影像组学使特征冗余减少约20%。

局限性

  • 原文为回顾性队列分析。
  • 作者在结论中提出未来研究应系统分析病灶及其周围区域,采用模糊与二值影像组学。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hybrid imaging became an instrumental part of medical imaging, particularly cancer imaging processes in clinical routine. To date, several radiomic and machine learning studies investigated the feasibility of in vivo tumor characterization with variable outcomes. This study aims to investigate the effect of recently proposed fuzzy radiomics and compare its predictive performance to conventional radiomics in cancer imaging cohorts. In addition, lesion vs. lesion+surrounding fuzzy and conventional radiomic analysis was conducted. METHODS: Previously published 11C Methionine (MET) positron emission tomography (PET) glioma, 18F-FDG PET/computed tomography (CT) lung, and 68GA-PSMA-11 PET/magneto-resonance imaging (MRI) prostate cancer retrospective cohorts were included in the analysis to predict their respective clinical endpoints. Four delineation methods including manually defined reference binary (Ref-B), its smoothed, fuzzified version (Ref-F), as well as extended binary (Ext-B) and its fuzzified version (Ext-F) were incorporated to extract imaging biomarker standardization initiative (IBSI)-conform radiomic features from each cohort. Machine learning for the four delineation approaches was performed utilizing a Monte Carlo cross-validation scheme to estimate the predictive performance of the four delineation methods. RESULTS: Reference fuzzy (Ref-F) delineation outperformed its binary delineation (Ref-B) counterpart in all cohorts within a volume range of 938-354987 mm3 with relative cross-validation area under the receiver operator characteristics curve (AUC) of +4.7-10.4. Compared to Ref-B, the highest AUC performance difference was observed by the Ref-F delineation in the glioma cohort (Ref-F: 0.74 vs. Ref-B: 0.70) and in the prostate cohort by Ref-F and Ext-F (Ref-F: 0.84, Ext-F: 0.86 vs. Ref-B: 0.80). In addition, fuzzy radiomics decreased feature redundancy by approx. 20%. CONCLUSIONS: Fuzzy radiomics has the potential to increase predictive performance particularly in small lesion sizes compared to conventional binary radiomics in PET. We hypothesize that this effect is due to the ability of fuzzy radiomics to model partial volume effects and delineation uncertainties at small lesion boundaries. In addition, we consider that the lower redundancy of fuzzy radiomic features supports the identification of imaging biomarkers in future studies. Future studies shall consider systematically analyzing lesions and their surroundings with fuzzy and binary radiomics.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Grahovac M, Spielvogel CP, Krajnc D, et al. Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts. Eur J Nucl Med Mol Imaging. 2023. PMID: 36738311. doi:10.1007/s00259-023-06127-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。